IQuum's research and development has been supported by Small Business Innovation Research (SBIR)-National Institutes of Health (NIH) grants. The SBIR grant application process, involving critical review by NIH experts in the field, has provided external validation of IQuum's technologies and product development approach.

The Company has established key collaborations with hospitals and research institutes, which will provide access to hospital laboratories and sample sources for clinical research in the development of in vitro diagnostic applications for the lab-in-a-tube technology.

IQuum is developing strategic partnerships with industry leaders for co-development and commercialization of lab-in-a-tube products for the in vitro diagnostic, biodefense, and industrial testing markets. We believe that IQuum's products and brand will be successfully launched through a powerful channel of distribution with the ability to rapidly capture a significant share of multiple markets. Such alliances will significantly benefit both IQuum and its strategic partners. We would like to share our vision and technologies with potential partners and encourage interested parties to contact us.